Mauff G, Luther B, Schneider P M, Rittner C, Stradmann-Bellinghausen B, Dawkins R, Moulds J M
Department Immunology, Virology, Vaccinations, State Institute of Hygiene, Hamburg, Germany.
Exp Clin Immunogenet. 1998;15(4):249-60. doi: 10.1159/000019079.
During the 7th Complement Genetics Workshop, Mainz, Germany, May 1998, a complement component C4 typing exercise took place with the aim of applying present technologies to the definition of reference C4 alleles/phenotypes and the recognition of nonexpressed (Q0) C4 alleles within expressed haplotypes. Eleven samples were submitted from 3 laboratories and tested by 14 participating laboratories with basic protein-typing technologies; in addition, each laboratory contributed data from local expertise. The samples were introduced to the reference typing for one or more characteristic allotype or for partial or total nonexpression of one isotype. The blinded samples were centrally evaluated and the results discussed among the participants at a plenum meeting. From the results, the samples could be classified into a group of common, easy to diagnose pheno-/allotypes, less common but still unanimously recognised variants, and a third group with difficult pheno-/allotypes. Within the latter group, the allotypes were either new (C4A '92'; C4B '93') and/or showed partial or total reversed antigenicity and unusual Rodgers/Chido (Rg/Ch) PCR subtypes (C4A '92'; C4A 12; C4B '35'; C4B '13'). Semiquantitative C4-alpha-chain estimates of relative isotype levels correlated well with the number of alleles seen at each locus by agarose gel electrophoresis, and were superior to other isotype quantitation methods. From the evaluation of the reference typing it was concluded that the recognition of rare, aberrant or hybrid C4 alleles with partial or total reversed Rg/Ch antigenicity or monoclonal reactivity is still difficult in most instances; besides isotype-dependent lysis, relative migration values, immunoblots with Rg- and Ch-specific monoclonal antibodies, Rg/Ch PCR typing, side-by-side comparison with already described allotypes will ultimately be required. The recognition of nonexpressed alleles within C4A and C4B expressed phenotypes remains the major obstacle in C4 genetic typing. Finally, a conclusive interpretation of DNA typing results will be achieved only in the context of complete allotyping results at the protein level, and at present cannot replace conventional protein allotyping.
1998年5月在德国美因茨举行的第七届补体遗传学研讨会上,进行了补体成分C4分型试验,目的是应用现有技术来定义参考C4等位基因/表型,并识别已表达单倍型内未表达的(Q0)C4等位基因。来自3个实验室的11个样本被提交,并由14个参与实验室使用基本蛋白质分型技术进行检测;此外,每个实验室还提供了来自当地专业知识的数据。这些样本被引入到针对一种或多种特征性同种异型或一种同种型的部分或完全不表达的参考分型中。对盲法样本进行集中评估,并在全体会议上让参与者讨论结果。根据结果,样本可分为一组常见的、易于诊断的表型/同种异型,不太常见但仍被一致认可的变体,以及第三组具有困难表型/同种异型的样本。在后者这一组中,同种异型要么是新的(C4A '92';C4B '93'),和/或表现出部分或完全反转的抗原性以及不寻常的Rodgers/Chido(Rg/Ch)PCR亚型(C4A '92';C4A 12;C4B '35';C4B '13')。相对同种型水平的半定量C4-α链估计与通过琼脂糖凝胶电泳在每个位点观察到的等位基因数量相关性良好,并且优于其他同种型定量方法。从参考分型的评估得出结论,在大多数情况下,识别具有部分或完全反转的Rg/Ch抗原性或单克隆反应性的罕见、异常或杂交C4等位基因仍然困难;除了同种型依赖性裂解、相对迁移值、用Rg和Ch特异性单克隆抗体进行的免疫印迹、Rg/Ch PCR分型外,最终还需要与已描述的同种异型进行并排比较。识别C4A和C4B已表达表型内未表达的等位基因仍然是C4基因分型中的主要障碍。最后,只有在蛋白质水平的完整同种异型分型结果的背景下才能实现对DNA分型结果的确切解释,并且目前不能取代传统的蛋白质同种异型分型。